Midostaurin is a new drug used for the treatment of:: (A) CML, (B) ALL, (C) AML, (D) CLL
Answer is C. Midostaurin : Multitargeted protein kinase inhibitor indicated along with standard cytarabine and daunorubicin for adult with newly diagnosed Acute Myeloid Leukemia (AML) who are FLT3 mutation positive.